TrialClinical cancer research : an official journal of the American Association for Cancer Research2026
A Phase Ib/IIa Study of Fostrox in Combination with Lenvatinib as Second-line Therapy in Patients with Advanced Hepatocellular Carcinoma.
Hong Jae Chon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.